Neurothrombectomy Devices Market Size to Surpass US$

Pune, Oct. 21, 2022 (GLOBE NEWSWIRE) — The global neurothrombectomy devices market is expected to clock US$ 1249.42 million by 2030. The global neurothrombectomy devices market is primarily driven by chronic diseases such as high blood pressure, high cholesterol, cardiovascular diseases, and the prevalence of ischemic stroke. Furthermore, technological advancement and the introduction of novel products contribute to the neurothrombectomy market expansion. However, the high cost of neurothrombectomy devices and the need for skilled personnel are impeding the growth of the neurothrombectomy market

A neurothrombectomy device is used to remove blood clots and retrieve clots as a therapy for ischemic stroke. Ischemic stroke occurs when a blood clot blocks blood flow to the brain, causing brain cells to die due to a lack of oxygen, resulting in stroke. Aspiration and clot retrieval devices are two types of neurothrombectomy devices.

Download PDF Brochure of Neurothrombectomy Devices Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/neurothrombectomy-devices-market/7902

Growth Drivers

Due to its rising incidence, high morbidity and mortality, and long-term psychological, physical, and social consequences, ischemic stroke at a young age is becoming a growing problem in both developing and developed countries. Stroke in young adults is more complex than stroke in older adults due to the wide range of possible underlying risk factors and etiologies. The growing prevalence of chronic diseases and lifestyle habits such as smoking, lack of exercise, etc. are responsible for ischemic stroke rising cases and driving the growth of the global neurothrombectomy devices market growth.

The global neurothrombectomy devices market has been analyzed from three different perspectives – Device type, end-user, and region.

Excerpts from ‘by Device Type’

The global neurothrombectomy…